ArticleFrontiers in medicine2026
Temporal and geographic trends in mortality involving co-occurring depression and diabetes mellitus in U. S., 1999-2023.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Diabetes mellitus (DM) and depression commonly co-occur, worsening self-management, complications, and survival. Yet long-term, population-based surveillance of mortality that involves both conditions remains limited. Objective: To characterize national trends in mortality co-listing diabetes and depression and to examine disparities by demographics and geography. Methods: We analyzed U. S. Multiple Cause-of-Death records from CDC WONDER for 1999-2023. Deaths that listed diabetes (ICD-10 E10-E14) and depressive disorders (ICD-10 F32-F33, F41.2) as underlying or contributing causes were included. We calculated crude and age-adjusted mortality rates (AAMRs) per 100,000, directly standardized to the 2000 U. S. population, and fitted segmented Joinpoint regression to estimate annual percent change (APC) and average APC. Stratifications included sex, age group, race/ethnicity, Census region, state, urban-rural category (2020 NCHS scheme applied uniformly across years), and place of death, with adherence to CDC WONDER suppression rules. Results: National AAMRs were low and broadly stable through the mid-to-late 2000s, rose in the late 2010s, and plateaued in the early 2020s. Rates were consistently higher in men than women and increased with age, peaking in adults aged 85 years or older. By race/ethnicity, non-Hispanic American Indian/Alaska Native populations had the highest AAMRs, followed by non-Hispanic Black and Hispanic groups, with non-Hispanic White and non-Hispanic Asian/Pacific Islander populations lower. Regionally, the West had the highest rates and the Northeast the lowest; nonmetropolitan counties exceeded metropolitan counties. States showed wide heterogeneity, with roughly threefold differences between the top and bottom deciles. Conclusion: Mortality involving co-occurring depression and diabetes shows an upswing in the late 2010s and substantial demographic and geographic inequalities. These findings support targeted, place-based strategies and integrated diabetes-mental health care to reduce preventable deaths.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.